ABBVIE INC (ABBV) Stock Analyst Ratings
NYSE:ABBV • US00287Y1091
232.08 USD
+7.39 (+3.29%)
At close: Feb 27, 2026
229.53 USD
-2.55 (-1.1%)
Pre-Market: 3/2/2026, 7:00:00 AM
ChartMill assigns a Buy % Consensus number of 77% to ABBV. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 255.68. This target is 10.17% above the current price.
- ABBV was analyzed by 37 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ABBV.
- In the previous month the buy percentage consensus was at a similar level.
- ABBV was analyzed by 37 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-25 | RBC Capital | Initiate | Outperform |
| 2026-02-20 | Barclays | Initiate | Overweight |
| 2026-02-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-05 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-05 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-27 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-08 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-12-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-10 | HSBC | Upgrade | Hold -> Buy |
| 2025-11-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-05 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-11-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-03 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-20 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-17 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-10-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-03 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-01 | HSBC | Downgrade | Buy -> Hold |
| 2025-09-22 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-17 | Berenberg | Upgrade | Hold -> Buy |
| 2025-09-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-09-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-09-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-01 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-01 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-08-01 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-14 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-04-29 | Guggenheim | Maintains | Buy -> Buy |
ABBVIE INC / ABBV FAQ
Can you provide the average price target for ABBVIE INC stock?
37 analysts have analysed ABBV and the average price target is 255.68 USD. This implies a price increase of 10.17% is expected in the next year compared to the current price of 232.08.
What is the consensus rating for ABBV stock?
The consensus rating for ABBVIE INC (ABBV) is 77.2973 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ABBV stock?
The number of analysts covering ABBVIE INC (ABBV) is 37.